2013.02.04 Weekly Broadcast Email
following updates were made to the CCCWFU CCOP Research Base website for the
week of February 4, 2013.
97211: (A Feasibility Study of Donepezil in Female Breast
Cancer Survivors with Self-Reported Cognitive Dysfunction Following
closure amendment approval letter has been posted to the archived amendment page.
The accrual goal for this study was achieved on January 24, 2013.
Many thanks to everyone who participated in this study.
are requesting the return of the Grooved Pegboard (Model 32025) and stop watch,
if loaned to your site. Once any current patients have completed the
study, please return
to Pegboard and stop watch to June Fletcher-Steede at:
Research Base PIO
2000 W. First
PPII, Suite 401
97609:(Impact of Genomics and Exposures on Disparities in Breast Cancer
Accrual update: As of
today, 789 of 1000 patients have been accrued to this study. There are
only 7 accruals remaining for African American patients. When these 7 accruals
are obtained, registration to this group will be closed. There are still
many accruals available for all other groups except Caucasians.
During the month
of January, 76 patients were accrued to CCCWFU CCOP Research Base trials.
Congratulations to CTSU and the Upstate CCOP for accruing the most
patients. See the Research Base website spotlight section for
were no adverse events received during the month of January.